email article The incidence of melanoma has been increasing in many countries but none faster than in Australia, where the costs associated with melanoma and other nonmelanoma skin cancers are the highest in the country's healthcare system. In 2014, results from a prospective 5-year follow-up study of primary melanoma in extreme high-risk patients from New South Wales showed that a structured surveillance program was less expensive and associated with more quality-adjusted life-years of survival than standard care. Subsequently, clinical practice guidelines from Cancer Council Australia recommended that patients at very high risk of melanoma be checked regularly by a clinician. The experts recommended full skin examinations every 6 months, supported by dermoscopy and sequential digital dermoscopy imaging (SDDI) and total-body photography (TBP).